MLTX INVESTMENT: MoonLake Immunotherapeutics Investors with Losses may have Rights in Securities Class Action – Contact BFA Law by December 15 Deadline
(NASDAQ:MLTX), NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain […]